rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-5-31
|
pubmed:abstractText |
The ATHENA trial (A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter) demonstrated that dronedarone reduced the risk of cardiovascular (CV) hospitalization/death by 24% (P < 0.001) in patients with atrial fibrillation (AF) and atrial flutter (AFL).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1932-8737
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2010 Wiley Periodicals, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
270-9
|
pubmed:meshHeading |
pubmed-meshheading:20513065-Aged,
pubmed-meshheading:20513065-Aged, 80 and over,
pubmed-meshheading:20513065-Amiodarone,
pubmed-meshheading:20513065-Anti-Arrhythmia Agents,
pubmed-meshheading:20513065-Atrial Fibrillation,
pubmed-meshheading:20513065-Atrial Flutter,
pubmed-meshheading:20513065-Controlled Clinical Trials as Topic,
pubmed-meshheading:20513065-Cost Savings,
pubmed-meshheading:20513065-Databases as Topic,
pubmed-meshheading:20513065-Drug Costs,
pubmed-meshheading:20513065-Female,
pubmed-meshheading:20513065-Hospital Costs,
pubmed-meshheading:20513065-Hospital Mortality,
pubmed-meshheading:20513065-Hospitalization,
pubmed-meshheading:20513065-Humans,
pubmed-meshheading:20513065-Inpatients,
pubmed-meshheading:20513065-Male,
pubmed-meshheading:20513065-Medicare Part B,
pubmed-meshheading:20513065-Models, Economic,
pubmed-meshheading:20513065-Retrospective Studies,
pubmed-meshheading:20513065-Time Factors,
pubmed-meshheading:20513065-Treatment Outcome,
pubmed-meshheading:20513065-United States
|
pubmed:year |
2010
|
pubmed:articleTitle |
Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
|
pubmed:affiliation |
Penn State Heart and Vascular Institute, Milton S. Hershey Medical Center, Penn State University, Hershey, Pennsylvania 17033, USA. gnaccarelli@hmc.psu.edu
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|